Krystal Biotech, Inc. KRYS FX Effect on Cash
FX Effect on Cash at other companies
Other financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s fx effect on cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s FX effect on cash?
- Krystal Biotech, Inc. (KRYS) reported FX effect on cash of -$1.33M in Q1 2026.
- How has Krystal Biotech, Inc.'s FX effect on cash changed year-over-year?
- Krystal Biotech, Inc.'s FX effect on cash decreased by 878.4% year-over-year, from $171K to -$1.33M.
- What does FX effect on cash mean?
- The impact of changing currency values on the company's cash balance.
- How do you interpret FX effect on cash?
- Minimal impact is generally preferred, as large fluctuations indicate significant exposure to currency volatility.
- How does FX effect on cash compare across companies?
- Typically low for companies with primarily domestic operations, but higher for those with international commercial footprints.